Arterys MICA
Arterys Inc. • Radiology • 03/25/2020
Device Purpose
Arterys MICA is a medical image processing software designed to assist healthcare professionals by displaying, processing, and managing DICOM and non-DICOM data, with optional AI modules for specialized analyses. Its core science involves applying computational algorithms for quantitative measurements in cardiovascular MR images and oncological CT/MR images to support, but not replace, clinical diagnosis and workflow.
Summary
Arterys MICA is a medical diagnostic software application designed for trained healthcare professionals to display, process, store, and transfer both DICOM and non-DICOM medical data, enhancing diagnostic workflows. It functions as an information and data management system where users can upload medical images such as CT or MR from PACS or scanners, manage patient information, and perform image manipulations including filtering, digital adjustments, and quantitative measurements. The system utilizes a client-server architecture, with a Chrome browser-based client and a Linux-based server, featuring a modular Viewer application for managing and viewing 2D and 3D images; it acts as a supportive tool, with clinicians retaining ultimate diagnostic responsibility. The platform's capabilities are significantly expanded by optional AI modules: Cardio AI and Oncology AI (comprising Lung AI and Liver AI). The Cardio AI module employs analytical techniques on multi-slice, multi-phase, and velocity-encoded cardiovascular magnetic resonance (MR) images (from 1.5T/3.0T scanners) to deliver reproducible, quantitative data on blood flow and ventricular function. The Oncology AI module utilizes algorithms to support oncological assessments from MR or CT images by aiding in the confirmation, evaluation, quantification, follow-up, and documentation of lesions, thereby assisting in morphological activity assessment during diagnosis and therapy monitoring. The software's performance and safety have been validated through extensive verification, including tests for mammography image display quality and comparisons to reference devices.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. How does the performance of the Cardio AI module in quantifying ventricular function and blood flow compare with established non-AI quantitative MR techniques in terms of accuracy and inter-observer variability?; What specific algorithms or machine learning models are employed by the Oncology AI module for lesion detection and quantification, and what was the reported sensitivity and specificity in validation studies across diverse patient populations and imaging protocols?; Can the Arterys MICA system be integrated with existing hospital Picture Archiving and Communication Systems (PACS) and Electronic Health Records (EHRs) from various vendors, and what are the technical requirements or limitations for such integrations?; How does the system handle non-DICOM data, and what types of non-DICOM medical data are supported for processing and quantitative analysis, particularly within the AI modules?; What are the minimum technical specifications for monitors and computer hardware to ensure optimal diagnostic image quality and performance of the AI-driven analytical tools, particularly given the allowance for mammography diagnostic viewing?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of ML-BOM, SaaSBOM, HBOM detected in AI-generated device summary.
• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.
• Not detected in AI-generated device summary: SBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly